Alvogen FDA Tuesday, January 21, 2020 0.00 Neutral

FDA Approves HYDROCODONE BITARTRATE — Alvogen Inc.

Alvogen Inc. filed a new generic application (ANDA206986) for oral hydrocodone bitartrate on January 21, 2020. This approval is expected to intensify competition in the generic narcotic market, potentially pressuring the pricing of this widely prescribed pain medication.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed